Consolidated Income Statements (USD $)	3 Months Ended
	Mar. 31, 2013		Mar. 31, 2012
Consolidated Income Statements
Gross sales	$ 4,172,334	[1]	$ 238,674
Program costs and discounts	(1,524,624)	[1]
Net sales	2,647,710	[1]	238,674
Costs of sales	1,424,669	[1]	67,088
Gross profit	1,223,041	[1]	171,586
Selling, general and administrative	2,211,714	[1]	160,277
Operating profit (loss)	(988,673)	[1]	11,309
Interest expense, net	236,996	[1]	264
Net income (loss)	(1,225,669)	[1]	11,045
Net income attributable to noncontrolling interest	23,445	[1]
Net income (loss) attributed to CVSL	$ (1,249,114)	[1]	$ 11,045
Basic and diluted income (loss) per share:
Weighted average common shares outstanding (in shares)	487,712,326	[1]	438,086,034

[1] Includes a full quarter of CVSL and HCG but only 13 days of results for TLC. Please see footnote (2).